Amphastar Pharmaceuticals, Inc.
AMPHNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 16, 2026 close
- Market cap
- $1.17B
- P/E (TTM)
- 14.88
- Forward P/E
- 26.76
- Dividend yield
- -
- 52-week range
- $16.65$29.52
- Volume (live)
- -
- Avg. volume (3M)
- 499.07K
Amphastar Pharmaceuticals (AMPH) Stock Price & Financial Analysis
Amphastar Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $25.52 - $26.61 |
|---|---|
| 52-Week High | $29.52 |
| 52-Week Low | $16.65 |
| Open | $26.61 |
| Volume (last close) | 351.98K |
| Average Volume (3M) | 499.07K |
| Revenue (TTM) | 730.02M |
|---|---|
| Net Income (TTM) | 78.55M |
| Free Cash Flow (TTM) | 152.89M |
| EPS (TTM) | $1.69 |
| Profit Margin | 10.76% |
| Operating Margin | 15.66% |
| Return on Equity (ROE) | 10.23% |
| Debt to Equity | 0.80 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.17B |
|---|---|
| Shares Outstanding | 44.23M |
| P/E Ratio (TTM) | 14.88 |
| Forward P/E | 26.76 |
| Price to Sales (P/S) | 1.60 |
| Price to Book (P/B) | 1.52 |
| EV/EBITDA | 8.14 |
| 50-Day MA | $23.45 |
|---|---|
| 200-Day MA | $22.33 |
| 1-Year Change | +11.10% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Amphastar Pharmaceuticals at a Glance
As of the Oct 16, 2026 close, Amphastar Pharmaceuticals (AMPH) has a market capitalization of $1.17B. The stock trades at 14.9× trailing earnings, 26.8× forward earnings and 1.6× sales. Over the trailing twelve months it earned $78.55M on revenue of $730.02M (a 10.8% profit margin) and generated $152.89M of free cash flow. Revenue grew 1.4% year over year.
As of its latest reported balance sheet, it holds $223.61M in cash and securities against $612.05M of debt, a net debt position of $388.44M.
Amphastar Pharmaceuticals does not currently pay a dividend.
The share price is up 11.1% over the past year. At $25.87 (the Oct 16, 2026 close) it sits within its 52-week range of $16.64 to $29.52, above its 200-day moving average of $22.33.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $22.17, 14.3% below the Oct 16, 2026 close.
Frequently Asked Questions About Amphastar Pharmaceuticals
What is the current stock price for AMPH?
As of the Oct 16, 2026 close, AMPH stock trades at $25.87. The 52-week range is $16.65–$29.52, with a day range of $25.52–$26.61.
What is the P/E ratio for AMPH?
As of the Oct 16, 2026 close, Amphastar Pharmaceuticals's trailing twelve-month (TTM) P/E ratio is 14.9, meaning investors pay $14.9 for every $1 of annual earnings. The forward P/E is 26.8, reflecting analyst expectations for future earnings. Amphastar Pharmaceuticals operates in the Healthcare sector.
Does AMPH pay dividends?
Amphastar Pharmaceuticals does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for AMPH?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for AMPH is Hold. The average 12-month price target is $22.17, a 14.3% downside from the Oct 16, 2026 close of $25.87.
What is the market cap of AMPH?
As of the Oct 16, 2026 close, Amphastar Pharmaceuticals's market capitalization is $1.14B, classifying it as a small-cap company. Amphastar Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.